Error: Could not add to watchlist. X
+ Watchlist

Carnegie Fund II - Biotechnology Sub-Fund

CARBIOA:LX
23.88
EUR
As of 12:00 AM EDT 5/3/2016
Fund Type
SICAV
52Wk Range
21.28 - 41.76
1 Yr Return
-31.30%
YTD Return
-28.12%
52Wk Range
21.28 - 41.76
1 Yr Return
-30.81%
YTD Return
-28.12%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 05/02/2016)
24.05
Total Assets (m EUR) (on 04/29/2016)
24.897
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%

Top Fund Holdings

Name Position Value % of Fund
24.90 k 2.01 m 9.12
22.50 k 1.98 m 8.97
8.36 k 1.88 m 8.51
19.30 k 1.34 m 6.06
29.50 k 1.12 m 5.07
14.39 k 1.02 m 4.62
8.00 k 963.53 k 4.36
2.93 k 929.45 k 4.21
23.00 k 922.74 k 4.18
6.00 k 666.56 k 3.02
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
Address
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
Phone
352-40-40-30-1